Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 avr. 2026 06h35 HE | Source: Research and Markets

Clinical Trial Monitoring Course: Understand the Importance of Compliance with the Latest GCP Standards (ONLINE EVENT: June 18th - June 19th, 2026)

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring (June 18th - June 19th, 2026)" training has been added to ResearchAndMarkets.com's offering.With regulatory inspectors...
14 avr. 2026 04h06 HE | Source: Research and Markets

AI & ML in Clinical Trials Fundamentals, Applications, and Regulatory Aspects Course: Technologies Crucial for Compliance and Leveraging Their Transformative Potential (ONLINE EVENT: May 11, 2026)

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ...
13 avr. 2026 09h42 HE | Source: Research and Markets

Conducting Clinical Trials in MENA Training Course: Ensuring the Safety, Efficacy, and Quality of Medical Products (ONLINE EVENT: May 6, 2026)

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trials in the MENA Region (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This course focuses on the MENA...
10 avr. 2026 08h30 HE | Source: Annovis Bio Inc.

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...
08 avr. 2026 09h21 HE | Source: Tekton Research Inc.

Tekton Research Opens First Multi-Specialty Clinical Research Hub in San Antonio

Tekton Research announces the opening of its San Antonio research hub, a physician-led clinical research center.
07 avr. 2026 09h28 HE | Source: Research and Markets

Dermatomyositis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Dermatomyositis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides top...
07 avr. 2026 09h27 HE | Source: Research and Markets

Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Market Review 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Human Immunodeficiency Virus (HIV) Infections (AIDS) - Global Clinical Trials Review, 2026" clinical trials has been added to ...
07 avr. 2026 09h25 HE | Source: Research and Markets

Psoriatic Arthritis Global Clinical Trials Market Review 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an...
06 avr. 2026 08h50 HE | Source: OneMedNet Corporation

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Dat
06 avr. 2026 06h30 HE | Source: Beacon Biosignals

Beacon Biosignals Upsizes Series B Financing to Over $97 Million

BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today announced an extension to its Series B financing, bringing the funding round to $97 million and the company’s cumulative funding to...

Page suivante